Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 7Uterine Cervical Neoplasms 4Vaginal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3Pancreatic Neoplasms 2Neuroendocrine Tumors 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Thrombocythemia, Essential 1Sezary Syndrome 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pancreatic Adenocarcinoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1

Interventions

Gemcitabine 54Specimen Handling 16Fluorouracil 15Radiotherapy 13Biopsy 12Oxaliplatin 10Magnetic Resonance Spectroscopy 10Erlotinib Hydrochloride 10Cyclophosphamide 10aldesleukin 8fludarabine 7Bevacizumab 7sargramostim 6Radiation 6veliparib 5Trastuzumab 5Leucovorin 5Cetuximab 5Capecitabine 5Taxes 4Sunitinib 4Irinotecan 4HhAntag691 4Cisplatin 42,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4tipifarnib 3rubitecan 3entinostat 3X-Rays 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Pancreatic Neoplasms × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT00085371 2013-10-08

Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

National Cancer Institute (NCI)

Phase 2 Completed
116 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00064051 2013-08-02

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡